Moleculin Biotech (MBRX) Q4 2024 Earnings

8NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-5.09
-3.96
-2.83
-1.7

Details

Expected EPS
-2.44
Actual EPS
-2.85
Surprise EPS
-0.41
Surprise Percent
+16.8%

Description

Moleculin Biotech (MBRX) has reported earnings of -2.85 per share for Q4 2024.

0 Comments

Share your thoughts